PharmaShots | Incisive News in 3 Shots

Subscribe Now

HER2-Positive Breast

Insights+ Key Biosimilars Events of May 2019

Insights+ Key Biosimilars Events of May 2019

June 4, 2019

Biocon and Mylan's Ogivri (trastuzumab- biosimilar) Receives Health Canada's Approval for HER2-Positive Breast and Gastric Cancers

Biocon and Mylan's Ogivri (trastuzumab- biosimilar) Receives Health Canada's Approval for HER2-Positive Breast and Gastric Cancers

May 22, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us